The goal of treatment in<unk>  is to reduce local inflammation and prevent the<unk>  from extending from its point of origin. Treatment may entail the use of compression, physical activity, medications, or surgical interventions. The optimal treatment for many<unk>  sites (i.e. upper limbs, neck, abdominal and thoracic walls, and the penis) has not been determined. Compression Multiple compression bandages exist. Fixed compression bandages, adhesive short stretch bandages, and graduated elastic compression stockings have all be used in the treatment of<unk> s. The benefit of compression stockings is unclear, though they are frequently used. Physical activity Inactivity is contraindicated in the aftermath of an<unk> . Uninterrupted periods of sitting or standing may cause the<unk>  to elongate from its point of origin, increasing the risk for complications and clinical worsening. Medications Medications used for the treatment of<unk>  include anticoagulants, NSAIDs (except aspirin), antibiotics, and corticosteroids. Anticoagulants<unk> s that occur within the great saphenous<unk>  within 3 cm of the saphenofemoral junction are considered to be equivalent in risk to DVTs. These high risk<unk> s are treated identically with therapeutic anticoagulation. Anticoagulation is also used for intermediate risk<unk> s that are greater than 3 cm from the saphenofemoral junction or are greater than 4–5 cm in length. Anticoagulation for high risk<unk> s includes the use of vitamin K antagonists or novel oral anticoagulants (NOACs) for 3 months. Anticoagulation for intermediate risk<unk> s includes fondaparinux 2.5 mg daily for 45 days or the use of intermediate to therapeutic dose low molecular weight heparin for 4–6 weeks. NSAIDs NSAIDs (non-steroidal anti-inflammatory drugs) can be used in both oral or topical formulations for the relief of<unk>  symptoms. The British Committee for Standards in Haematology guidelines recommend the use of NSAIDs for low-risk<unk> s (thrombus <4–5 cm in length, no additional risk factors for thromboembolic events). NSAIDs are used for treatment durations of 8–12 days. Other Antibiotics are used in the treatment of septic<unk> . Corticosteroids are used for the treatment of<unk> s in the setting of vasculitic and autoimmune syndromes. Surgery Surgical interventions are used for both symptomatic relief of the<unk>  as well as for preventing the development of more serious complications (e.g. pulmonary embolism). Surgical interventions include ligation of the saphenofemoral junction, ligation and stripping of the affected<unk> s, and local thrombectomy. Because of the risk of symptomatic pulmonary embolism with surgery itself, surgical interventions are not recommended for the treatment of lower limb<unk> s by the 2012 American College of Chest Physicians guidelines and the 2012 British Committee for Standards in Haematology guidelines. The use of surgery for the treatment of<unk>  is controversial.
Superficial vein thrombosis
Varicose veins
Superficial thrombophlebitis
Popliteal artery aneurysm
Venous ulcer
Septic thrombophlebitis
Pseudothrombophlebitis
Raynaud syndrome